FDA Inspection 594632 — Kirk Pharmaceuticals, LLC

Kirk Pharmaceuticals, LLC — FEI 3003104863

The FDA completed an inspection of Kirk Pharmaceuticals, LLC on July 2, 2009 in Fort Lauderdale, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 2, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fort Lauderdale, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
138421 CFR 211.101(c)Weighing/measuring/subdividing supervision
189121 CFR 211.165(f)Failing drug products not rejected
194321 CFR 211.180(e)(1)Review of representative number of batches
202721 CFR 211.192Investigations of discrepancies, failures
202821 CFR 211.192Extent of discrepancy, failure investigations
360321 CFR 211.160(b)Scientifically sound laboratory controls